Gastroenterology

  • Colorectal cancer screening
    Joseph B. Weiss, MD, Nancy S. Cetel, MD and Danielle E. Weiss, MD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774-776; DOI: https://doi.org/10.3949/ccjm.86c.12002
  • Colorectal cancer screening
    Mark R. Goldstein, MD, FACP, Luca Mascitelli, MD and Zakia H. Rauf, MD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774; DOI: https://doi.org/10.3949/ccjm.86c.12001
  • In reply: The authors reply
    Carol A. Burke, MD, Gautam Mankaney, MD and Richard Andrew Sutton, DO
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 776-777; DOI: https://doi.org/10.3949/ccjm.86c.12003
  • Functional heartburn: An underrecognized cause of PPI-refractory symptoms
    Functional heartburn: An underrecognized cause of PPI-refractory symptoms
    Scott Gabbard, MD and Sonya Vijayvargiya
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 799-806; DOI: https://doi.org/10.3949/ccjm.86a.19006

    Functional heartburn is the most common cause of failure of proton pump inhibitor therapy.

  • Beyond depression: Other uses for tricyclic antidepressants
    Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

    The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

  • Current management of Barrett esophagus and esophageal adenocarcinoma
    Current management of Barrett esophagus and esophageal adenocarcinoma
    Tavankit Singh, MD, Vedha Sanghi, MD and Prashanthi N. Thota, MD, FACG
    Cleveland Clinic Journal of Medicine November 2019, 86 (11) 724-732; DOI: https://doi.org/10.3949/ccjm.86a.18106

    Risk factors: reflux symptoms > 5 years, male sex, age > 50, white race, central obesity, and smoking.

  • Vulvar and gluteal manifestations of Crohn disease
    Anna Camille Moreno, DO, NCMP, Oluwatosin Goje, MD, MSCR, FACOG, Melissa Peck Piliang, MD, FAAD and Pelin Batur, MD, NCMP, CCD
    Cleveland Clinic Journal of Medicine October 2019, 86 (10) 645-646; DOI: https://doi.org/10.3949/ccjm.86a.19062

    Crohn disease is associated with extraintestinal manifestations in up to 45% of patients.

  • Hemorrhoids: A range of treatments
    Hemorrhoids: A range of treatments
    Turgut Bora Cengiz, MD and Emre Gorgun, MD, FACS, FASCRS
    Cleveland Clinic Journal of Medicine September 2019, 86 (9) 612-620; DOI: https://doi.org/10.3949/ccjm.86a.18079

    Each patient is unique, and with the range of options available, treatment can be individualized.

  • Gastroparesis
    Amos Lal, MD, Pantea Ebrahimpour, MD and Nitin Trivedi, MD, FACP, FACE
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 514; DOI: https://doi.org/10.3949/ccjm.86c.08001

    A reader raises questions about diabetic gastroparesis (April 2019).

  • In reply: Gastroparesis
    Ahmad Muneer Sharayah, MD, Noor Hajjaj, MD, Ramy Osman, MD and Douglas Livornese, MD
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 514; DOI: https://doi.org/10.3949/ccjm.86c.08002

Pages